| |
|
|
|
|
| December 3,
2009 | ISSUE NUMBER 127 VOL 7 |
Reform
Report Sees Huge Pharma Tax Hike Over Next Decade
A new study of industry tax professionals conducted by PricewaterhouseCoopers predicts higher taxes for Big Pharma in the wake of the global economic downturn. What can your company do to remain competitive and discover new incentives?
Restructuring
Big Cuts Hit Sanofi-Aventis Sales Force
The long rumored job cuts at Sanofi-Aventis were finally announced on Monday as the company eliminated more than 10% of its current sales force
Marketing
Lilly Launches Depression Web Site
Using a targeted survey and a short and sweet action plan, Lilly is banking that its new unbranded Web site will steer depression sufferers in the right direction.
Global
The EU Pharma Switch
Pharm Exec was live at the joint meetings of the European Medicines Agency and the Organization for Professionals in Regulatory Affairs in London. Here’s the latest news from across the pond.
New & Noteworthy
Marketing's Stepchild No More
In today's "show me the money" marketplace, reimbursement strategy must involve more than seeking a good price based on ability to pay. |
 |
|  AbelsonTaylor hired Alex Kramer as interactive producer and promoted Matt Monnin to senior producer and Steve Kakos to associate interactive developer
// Karolinska Development AB and Pergamum AB appointed Jorgen Thorball as chairman of the board of directors of Pergamum AB
// Santen Inc. President and CEO Adrienne L. Graves was appointed to the board of directors of the American Society of Cataract and Refractive Surgery Foundation
// J.R. Meloro was named executive vice president, managing director of Medicus International New York
// Map Pharmaceuticals appointed Alan Petro to vice president, manufacturing and technical operations
// Nektar Therapeutics promoted Lorianne Masuoka to senior vice president and chief medical officer
//
|
Advertisement:
CBI’s 7th Annual Pharmaceutical Compliance Congress — January 25-26, 2010, Washington, DC
The Premier Life Science Compliance Forum Led by Industry Compliance Professionals. Thousands of high-level executives have benefited! Engage in interactive discussions surrounding legal, regulatory and compliance. Hear from top industry and government experts from GSK, J&J, sanofi-aventis, Bayer HealthCare, Eli Lilly, Pfizer, CALPIRG, the FDA and more! To register, call 800-817-8601 or visit
 www.cbinet.com/pcc. |
Dec 8–9, 2009 Forum on FDA’s Structured Product Labeling, Washington, DC
Jan 21–22, 2010 Bio/Pharmaceutical Forum on Optimizing the Use of Complex Data Assets,
Philadelphia, PA
Jan 25–26, 2010 Bio/Pharmaceutical Forum on Strategic Sourcing and Procurement,
Philadelphia, PA
Feb 8–9, 2010 3rd Annual Clinical Trial Forecasting and Budgeting, Philadelphia, PA
April 12–14, 2010 19th Annual Partnerships in Clinical Trials, Orlando FL
|
|
|
|
 |
|
 |
|
 |
| Should FDA recognize social media as a new form of communication with its own rules and regulations? |
|
|
|
|
You are subscribed to Pharm Exec Direct..
To unsubscribe,
click here
To ensure delivery to your Inbox, please add us to your address book. If you need help doing this, click here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
|
|
